Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Simon

Showing results (261-270 of 494) with videos related to

Pageof 50
Sort By:
Histopathology|July 17, 2013
MALDI imaging on large-scale tissue microarrays identifies molecular features associated with tumour phenotype in oesophageal cancerAlexander Quaas, Ahmad Soliaman Bahar, Katharina von Loga, et al.
The Journal of Pathology|December 4, 2003
High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancerBoriana M Zaharieva, Ronald Simon, Pierre-Andre Diener, et al.
Oncology Letters|October 19, 2018
High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastasesFranziska Brandi, Katharina Grupp, Claudia Hube-Magg, et al.
BMC Cancer|June 18, 2010
Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lungTatyana Kalinina, Cenap Güngör, Sabrina Thieltges, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 23, 2016
p16 upregulation is linked to poor prognosis in ERG negative prostate cancerChristoph Burdelski, Tatsiana Dieckmann, Asmus Heumann, et al.
The Journal of Pathology|June 25, 2013
Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancersAntje Krohn, Annemarie Seidel, Lia Burkhardt, et al.
The Prostate|January 15, 2016
Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancerNathaniel Melling, Berivan Taskin, Claudia Hube-Magg, et al.
Plos One|August 1, 2015
High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate CancerNathaniel Melling, Levon Harutyunyan, Claudia Hube-Magg, et al.
Endocrine Pathology|March 8, 2020
Homogeneous MMR Deficiency Throughout the Entire Tumor Mass Occurs in a Subset of Colorectal Neuroendocrine CarcinomasChristoph Fraune, Ronald Simon, Claudia Hube-Magg, et al.
Oncology Reports|July 3, 2015
Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletionKatharina Grupp, Laura Roettger, Martina Kluth, et al.
Pageof 50

Showing results (261-270 of 494) with videos related to

Sort By:
Pageof 50
Histopathology|July 17, 2013
MALDI imaging on large-scale tissue microarrays identifies molecular features associated with tumour phenotype in oesophageal cancerAlexander Quaas, Ahmad Soliaman Bahar, Katharina von Loga, et al.
The Journal of Pathology|December 4, 2003
High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancerBoriana M Zaharieva, Ronald Simon, Pierre-Andre Diener, et al.
Oncology Letters|October 19, 2018
High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastasesFranziska Brandi, Katharina Grupp, Claudia Hube-Magg, et al.
BMC Cancer|June 18, 2010
Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lungTatyana Kalinina, Cenap Güngör, Sabrina Thieltges, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 23, 2016
p16 upregulation is linked to poor prognosis in ERG negative prostate cancerChristoph Burdelski, Tatsiana Dieckmann, Asmus Heumann, et al.
The Journal of Pathology|June 25, 2013
Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancersAntje Krohn, Annemarie Seidel, Lia Burkhardt, et al.
The Prostate|January 15, 2016
Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancerNathaniel Melling, Berivan Taskin, Claudia Hube-Magg, et al.
Plos One|August 1, 2015
High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate CancerNathaniel Melling, Levon Harutyunyan, Claudia Hube-Magg, et al.
Endocrine Pathology|March 8, 2020
Homogeneous MMR Deficiency Throughout the Entire Tumor Mass Occurs in a Subset of Colorectal Neuroendocrine CarcinomasChristoph Fraune, Ronald Simon, Claudia Hube-Magg, et al.
Oncology Reports|July 3, 2015
Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletionKatharina Grupp, Laura Roettger, Martina Kluth, et al.
Pageof 50